Berlin - Delayed Quote • EUR vTv Therapeutics Inc. R (5VT0.BE) Follow Compare 15.10 +0.10 (+0.67%) At close: November 29 at 9:40 PM GMT+1 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 5VT0.BE 1D 5D 7.86% 1M 11.85% 6M 17.97% YTD 17.97% 1Y 17.97% 2Y -52.29% 5Y -72.24% All -77.53% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: 5VT0.BE View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations vTv Therapeutics (NASDAQ:VTVT) adds US$9.5m to market cap in the past 7 days, though investors from five years ago are still down 71% VTv Therapeutics: Q3 Earnings Snapshot vTv Therapeutics Announces 2024 Third Quarter Financial Results and Provides Corporate Update vTv Therapeutics Faces License Agreement Termination We're Keeping An Eye On vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Rate VTv Therapeutics: Q2 Earnings Snapshot vTv Therapeutics Announces 2024 Second Quarter Financial Results and Provides Corporate Update FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks FDA places vTv Therapeutics’s cadisegliatin programme on clinical hold vTv Therapeutics' Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold; Shares Sink vTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold